Optas LLC’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$236K Sell
3,020
-2,837
-48% -$229K 0.03% 393
2026
Q1
$508K Sell
5,857
-892
-13% -$85.5K 0.08% 160
2025
Q4
$648K Buy
6,749
+2,210
+49% +$215K 0.1% 135
2025
Q3
$432K Sell
4,539
-3,169
-41% -$291K 0.07% 180
2025
Q2
$672K Buy
7,708
+3,879
+101% +$329K 0.13% 100
2025
Q1
$344K Buy
3,829
+38
+1% +$3.4K 0.06% 179
2024
Q4
$303K Sell
3,791
-103
-3% -$8.92K 0.07% 179
2024
Q3
$351K Buy
3,894
+707
+22% +$59.5K 0.08% 148
2024
Q2
$251K Sell
3,187
-2,193
-41% -$180K 0.06% 169
2024
Q1
$469K Sell
5,380
-868
-14% -$74.1K 0.13% 97
2023
Q4
$515K Sell
6,248
-2,117
-25% -$161K 0.15% 85
2023
Q3
$655K Buy
8,365
+334
+4% +$28K 0.22% 70
2023
Q2
$708K Buy
8,031
+177
+2% +$15.2K 0.24% 72
2023
Q1
$633K Buy
7,854
+523
+7% +$42.6K 0.23% 76
2022
Q4
$570K Sell
7,331
-4,992
-41% -$405K 0.24% 68
2022
Q3
$992K Sell
12,323
-48
-0.4% -$4.31K 0.44% 41
2022
Q2
$1.11M Sell
12,371
-672
-5% -$68.1K 0.45% 38
2022
Q1
$1.45M Buy
13,043
+974
+8% +$103K 0.47% 35
2021
Q4
$1.25M Sell
12,069
-39
-0.3% -$4.52K 0.35% 42
2021
Q3
$1.52M Sell
12,108
-768
-6% -$99.4K 0.44% 36
2021
Q2
$1.6M Buy
12,876
+731
+6% +$91.8K 0.46% 33
2021
Q1
$1.44M Sell
12,145
-3,652
-23% -$428K 0.45% 33
2020
Q4
$1.85M Sell
15,797
-5,910
-27% -$651K 0.59% 27
2020
Q3
$2.25M Buy
21,707
+7,227
+50% +$726K 0.69% 25
2020
Q2
$1.33M Buy
14,480
+2,474
+21% +$237K 0.54% 29
2020
Q1
$1.08M Sell
12,006
-2,712
-18% -$289K 0.54% 26
2019
Q4
$1.67M Buy
+14,718
New +$1.62M 0.64% 21

Other funds holding MDT

Optas LLC's MDT Position: Q2 2026 in Review

Optas LLC reduced its Medtronic (MDT) stake by 48% in Q2 2026, selling an estimated $229K and leaving 3,020 shares worth $236K. The position accounts for 0.03% of the portfolio, ranked #393.

Optas LLC first reported a position in MDT in Q4 2019 and has held it in 27 quarters since. The position peaked at $2.25M in Q3 2020. 613 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Optas LLC held 3,020 shares of Medtronic worth $236K as of Q2 2026.
  • Optas LLC sold 2,837 Medtronic shares in Q2 2026, an estimated $229K.
  • Medtronic made up 0.03% of Optas LLC's portfolio in Q2 2026, its #393 holding.
  • Optas LLC first reported a position in Medtronic in Q4 2019 and has held it in 27 quarters since.
  • Optas LLC's Medtronic position peaked at $2.25M in Q3 2020.
  • 613 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Optas LLC's 13F filing for Q2 2026, filed 21 Jul 2026.